Inactivation and survival of hepatitis C virus on inanimate surfaces

Journal of Infectious Diseases

Volumn 204, Issue 12, 2011, Pages 1830-1838

  Doerrbecker, Juliane ^a   Friesland, Martina ^a   Ciesek, Sandra ^a,b   Erichsen, Thomas J ^b   Mateu Gelabert, Pedro ^e   Steinmann, Jörg ^c   Steinmann, Jochen ^d   Pietschmann, Thomas ^a   Steinmann, Eike ^a  

^a INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d MikroLab GmbH   (Germany)

^e NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISINFECTANT AGENT; PROPANOL;

ARTICLE; ASSAY; CARRIER ASSAY; CONTROLLED STUDY; DRUG TRANSMISSION ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; INANIMATE SURFACE; NONHUMAN; PRIORITY JOURNAL; SERUM; SURFACE PROPERTY; TEMPERATURE; VIRUS CULTURE; VIRUS INACTIVATION; VIRUS INFECTIVITY; VIRUS SURVIVAL; VIRUS TRANSMISSION;

1-PROPANOL; 2-PROPANOL; DISINFECTANTS; EQUIPMENT CONTAMINATION; ETHANOL; GLUTARAL; HEPACIVIRUS; HEPATITIS C; HUMANS; MICROBIAL VIABILITY; PEROXIDES; QUATERNARY AMMONIUM COMPOUNDS; SUBSTANCE ABUSE, INTRAVENOUS; TEMPERATURE; TIME FACTORS; VIRUS INACTIVATION;

EID: 81055147115     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir535     Document Type: Article

References (40)

1. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007; 13:2436-41. (Pubitemid 46929498)
2. Simmonds P, Bukh J, Combet C, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005; 42:962-73. (Pubitemid 41401136)
3. Hoofnagle JH. Hepatitis C: the clinical spectrum of disease. Hepatology 1997; 26:15S-20S. (Pubitemid 27388066)
4. Manns MP, Wedemeyer H, Cornberg M. Treating viral hepatitis C: efficacy, side effects, and complications. Gut 2006; 55:1350-9. (Pubitemid 44277369)
5. Esteban JI, Gomez J, Martell M, et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996; 334:555-60. (Pubitemid 26066128)
6. Macedo de Oliveira A, White KL, Leschinsky DP, et al. An outbreak of hepatitis C virus infections among outpatients at a hematology/oncology clinic. Ann Intern Med 2005; 142:898-902.
7. Williams IT, Perz JF, Bell BP. Viral hepatitis transmission in ambulatory health care settings. Clin Infect Dis 2004; 38:1592-8. (Pubitemid 38738557)
8. Murphy EL, Bryzman SM, Glynn SA, et al. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS). Hepatology 2000; 31:756-62. (Pubitemid 30118647)
9. Deterding K, Wiegand J, Gruner N, Wedemeyer H. Medical procedures as a risk factor for HCV infection in developed countries: do we neglect a significant problem in medical care? J Hepatol 2008; 48:1019-20; author reply 1020-1.
10. Busch MP, Wilber JC, Johnson P, Tobler L, Evans CS. Impact of specimen handling and storage on detection of hepatitis C virus RNA. Transfusion 1992; 32:420-5.
11. Comstock RD, Mallonee S, Fox JL, et al. A large nosocomial outbreak of hepatitis C and hepatitis B among patients receiving pain remediation treatments. Infect Control Hosp Epidemiol 2004; 25:576-83. (Pubitemid 38954488)
12. Krause G, Trepka MJ, Whisenhunt RS, et al. Nosocomial transmission of hepatitis C virus associated with the use of multidose saline vials. Infect Control Hosp Epidemiol 2003; 24:122-7. (Pubitemid 36206080)
13. Lagging LM, Aneman C, Nenonen N, et al. Nosocomial transmission of HCV in a cardiology ward during the window phase of infection: an epidemiological and molecular investigation. Scand J Infect Dis 2002; 34:580-2. (Pubitemid 35012340)
14. Forns X, Martinez-Bauer E, Feliu A, et al. Nosocomial transmission of HCV in the liver unit of a tertiary care center. Hepatology 2005; 41:115-22. (Pubitemid 40066389)
15. Silini E, Locasciulli A, Santoleri L, et al. Hepatitis C virus infection in a hematology ward: evidence for nosocomial transmission and impact on hematologic disease outcome. Haematologica 2002; 87:1200-8. (Pubitemid 35397780)
16. Thorpe LE, Ouellet LJ, Hershow R, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol 2002; 155:645-53. (Pubitemid 34246097)
17. Koester S, Glanz J, Baron A. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. AIDS Behav 2005; 9:27-39. (Pubitemid 40562182)
18. Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health 2001; 91:42-6. (Pubitemid 32049265)
19. Alter MJ. Prevention of spread of hepatitis C. Hepatology 2002; 36:S93-8. (Pubitemid 35253468)
20. Shapshak P, Somboonwit C, Drumright LN, et al. Molecular and contextual markers of hepatitis C virus and drug abuse. Mol Diagn Ther 2009; 13:153-79.
21. Zhong J, Gastaminza P, Cheng G, et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 2005; 102:9294-9. (Pubitemid 40923557)
22. Wakita T, Pietschmann T, Kato T, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005; 11:791-6. (Pubitemid 41021213)
23. Lindenbach BD, Evans MJ, Syder AJ, et al. Complete replication of hepatitis C virus in cell culture. Science 2005; 309:623-6. (Pubitemid 41033648)
24. Ciesek S, Friesland M, Steinmann J, et al. How stable is the hepatitis C virus (HCV)? Environmental stability of HCV and its susceptibility to chemical biocides. J Infect Dis 2010; 201:1859-66.
25. Paintsil E, He H, Peters C, Lindenbach BD, Heimer R. Survival of hepatitis C virus in syringes: implication for transmission among injection drug users. J Infect Dis 2010; 202:984-90.
26. Pietschmann T, Kaul A, Koutsoudakis G, et al. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci USA 2006; 103:7408-13. (Pubitemid 43727846)
27. Yanagi M, Purcell RH, Emerson SU, Bukh J. Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras. Virology 1999; 262:250-63. (Pubitemid 29455022)
28. Koutsoudakis G, Kaul A, Steinmann E, et al. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J Virol 2006; 80:5308-20.
29. Sattar SA, Springthorpe VS, Adegbunrin O, Zafer AA, Busa M. A discbased quantitative carrier test method to assess the virucidal activity of chemical germicides. J Virol Methods 2003; 112:3-12. (Pubitemid 37338253)
30. Hahn JA, Page-Shafer K, Lum PJ, et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis 2002; 186:1558-64. (Pubitemid 35379631)
31. Gottwein JM, Bukh J. Cutting the Gordian knot-development and biological relevance of hepatitis C virus cell culture systems. Adv Virus Res 2008; 71:51-133.
32. Kamili S, Krawczynski K, McCaustland K, Li X, Alter MJ. Infectivity of hepatitis C virus in plasma after drying and storing at room temperature. Infect Control Hosp Epidemiol 2007; 28:519-24. (Pubitemid 46814539)
33. Nascimbeni M, Mizukoshi E, Bosmann M, et al. Kinetics of CD41 and CD81 memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees. J Virol 2003; 77:4781-93. (Pubitemid 36402828)
34. Meyer MF, Lehmann M, Cornberg M, et al. Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response. Virol J 2007; 4:58.
35. Bond WW, Favero MS, Petersen NJ, Gravelle CR, Ebert JW, Maynard JE. Survival of hepatitis B virus after drying and storage for one week. Lancet 1981; 1:550-1.
36. Edlin BR, Carden MR. Injection drug users: the overlooked core of the hepatitis C epidemic. Clin Infect Dis 2006; 42:673-6. (Pubitemid 43271381)
37. Heimer R. Syringe exchange programs: lowering the transmission of syringe-borne diseases and beyond. Public Health Rep 1998; 113(Suppl 1):67-74. (Pubitemid 29330147)
38. Gerberding JL. Management of occupational exposures to blood-borne viruses. N Engl J Med 1995; 332:444-51.
39. Short LJ, Bell DM. Risk of occupational infection with blood-borne pathogens in operating and delivery room settings. Am J Infect Control 1993; 21:343-50. (Pubitemid 24020091)
40. Rich JD, Taylor LE. The beginning of a new era in understanding hepatitis C virus prevention. J Infect Dis 2010; 202:981-3.